Kaplan-Meier survival analysis showed that patients whose tumors overexpressed USP4 had poor overall survival, and it combined with cyclophilin A (CypA) to form a complex to activate the MAPK signaling pathway in HCC (151). This evidence concerns the gene USP4 and hepatocellular carcinoma.